The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 12, 2019
Filed:
Feb. 13, 2018
Applicant:
Welt Bio-molecular Pharmaceutlical, Llc, Armonk, NY (US);
Inventors:
Sydney Welt, Armonk, NY (US);
David Kostyal, Akron, OH (US);
Rachel S Welt, Armonk, NY (US);
Virginia Raymond, Armonk, NY (US);
Jonathan A Welt, Armonk, NY (US);
Assignee:
Welt Bio-Molecular Pharmaceutical, LLC., Armonk, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 39/40 (2006.01); C12P 21/06 (2006.01); C07K 16/42 (2006.01); C12N 5/16 (2006.01); C07K 16/00 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
C07K 16/4283 (2013.01); C12N 5/163 (2013.01); C07K 16/2803 (2013.01); C07K 2317/14 (2013.01); C07K 2317/34 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/73 (2013.01); C07K 2317/732 (2013.01); C07K 2317/76 (2013.01); C07K 2317/77 (2013.01);
Abstract
The present invention relates to antibodies targeting the membrane bound IgM (mIgM) of the B-cell receptor complex found in B-cell lymphomas and leukemias and uses thereof. Another aspect of the present invention is the use of anti-B-Cell mIgM antibodies in the treatment of Be-cell malignancies, including B-cell lymphomas and leukemias.